Acthar and Vitamin d3 drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Acthar (corticotropin) and Vitamin d3 (cholecalciferol). Common drug interactions include stent placement among females and insomnia among males.

The phase IV clinical study analyzes what interactions people have when they take Acthar and Vitamin d3. It is created by eHealthMe based on reports of 62 people who take the same drugs from the FDA, and is updated regularly.

What is Acthar?

Acthar has active ingredients of corticotropin. eHealthMe is studying from 4,948 Acthar users. Check the latest studies of Acthar.

What is Vitamin d3?

Vitamin d3 has active ingredients of cholecalciferol. It is often used in heart health. eHealthMe is studying from 32,172 Vitamin d3 users. Check the latest studies of Vitamin d3.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 24, 2026

62 people who take Acthar and Vitamin d3 together, and have interactions are studied.

Acthar and Vitamin d3 drug interactions.

What are the common drug interactions of Acthar and Vitamin D3, by gender? *:

female:

  1. Stent placement
  2. Urine abnormality
  3. Vision blurred
  4. White blood cell count increased
  5. Adverse reaction
  6. Arthralgia (joint pain)
  7. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  8. Back pain
  9. Blood creatinine increased
  10. Blood potassium decreased

male:

  1. Insomnia (sleeplessness)
  2. Chronic kidney disease
  3. Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells)
  4. Urinary tract infection
  5. Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)
  6. Injection site bruising
  7. Injection site erythema (redness at injection site)
  8. Macrocytosis (enlargement of red blood cells with near-constant haemoglobin concentration)
  9. Staphylococcal sepsis (blood infection by an infection with staphylococcus bacteria)
  10. Urinary tract infection staphylococcal

What are the common drug interactions of Acthar and Vitamin D3, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
  2. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)

30-39:

  1. Drug ineffective
  2. Optic neuritis (optic nerve inflammation)
  3. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  4. Injection site erythema (redness at injection site)
  5. Insomnia (sleeplessness)
  6. Pyrexia (fever)
  7. Anaemia (lack of blood)
  8. Infection
  9. Nephrotic syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema)
  10. Pain

40-49:

  1. Proteinuria (presence of protein in the urine)
  2. Urine abnormality
  3. Adrenocortical insufficiency acute (suddenly adrenal glands do not produce adequate amounts of steroid hormones)
  4. Anaemia (lack of blood)
  5. Arthropathy
  6. Blood creatinine increased
  7. Blood glucose increased
  8. Dyspnoea (difficult or laboured respiration)
  9. Infusion site hypersensitivity
  10. Peripheral swelling

50-59:

  1. Urinary tract infection staphylococcal
  2. Vision blurred
  3. Aphasia (damage to the parts of the brain that control language)
  4. Arthralgia (joint pain)
  5. Blood glucose increased
  6. Burning sensation
  7. Dehydration (dryness resulting from the removal of water)
  8. Disturbance in attention
  9. Feeling cold
  10. Feeling jittery

60+:

  1. Headache (pain in head)
  2. Erythema (redness of the skin)
  3. Pain
  4. Swelling
  5. Abdominal discomfort
  6. Back pain
  7. Benign prostatic hyperplasia (benign enlargement of the prostate)
  8. Calculus bladder (bladder stone)
  9. Depression
  10. Dyspnoea (difficult or laboured respiration)

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 20 people, 32.26%
  2. Pain: 11 people, 17.74%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 8 people, 12.90%
  4. High Blood Pressure: 5 people, 8.06%
  5. High Blood Cholesterol: 5 people, 8.06%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 8.06%
  7. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 4 people, 6.45%
  8. Renal Disorder (kidney disease): 4 people, 6.45%
  9. Panic Disorder: 4 people, 6.45%
  10. Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Acthar and Vitamin d3?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Acthar and Vitamin d3:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Acthar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vitamin d3:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Acthar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vitamin d3 and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on corticotropin and cholecalciferol (the active ingredients of Acthar and Vitamin d3, respectively), and Acthar and Vitamin d3 (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: